Iris Tavor

Iris Tavor is a seasoned regulatory affairs professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Head of Regulatory Affairs at ImmunoBrain Checkpoint since March 2024, Iris has also held significant roles at Enlivex Therapeutics, including Senior Director of RA/QA and Head of Regulatory Affairs, and at Pluristem Therapeutics as Director of Regulatory Affairs and QA/QC Director. Previous experience includes positions at Teva API Division and Taro Pharmaceuticals. Iris holds a Master’s degree in Quality Assurance and a Bachelor’s degree in Quality Assurance in Biotechnology, both from the Technion - Israel Institute of Technology.